pre-ipo
Stage
About
Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases.
Explore Cartesian Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.